logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
T

Thomas Zilli

oncology institute of southern switzerland

40H-index
386Paper Count
5.7KCitation Count
Published Papers 191
Publication Date
logo
Stereotactic radiotherapy for rib metastases from prostate cancer: A multicenter real-world analysis of local control, pain response, and treatment tolerance (RIBRISK)
errTherapeutic Advances in Medical Oncology
IF4.2
err2026-08-18
err0
PREAI
errMateusz Bilski; Federico Mastroleo; Igor Banaszek; Katarzyna Korab; Wojciech Kuźnicki; Nina Jędrzejczak; Magdalena Peszyńska-Piorun; Julia Ponikowska; Jacek Fijuth; Barbara Alicja Jereczek Fossa; Thomas Zilli; Rupesh Kotecha; Shankar Siva; Matthias Guckenberger; Amar Kishan; Łukasz Kuncman
errShare
errSave
Reply to Kelly M. de Ligt, Sarah P. Psutka, and Laura S. Mertens’s Letter to the Editor Re: Martino Pedrani, Alberto De Giorgi, Andrea Gallina, et al. When Patients Refuse Radical Cystectomy: Integrating Trimodality Therapy in the Perioperative ICI/ADC Era. Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2026.04.008
errEuropean Urology Oncology
IF9.3
err2026-07-29
err0
PREAI
errMartino Pedrani; Alberto De Giorgi; Andrea Gallina; Ursula Vogl; Thomas Zilli
errShare
errSave
Beyond Prostate-Specific Antigen and Conventional Imaging: How Prostate-Specific Membrane Antigen Positron Emission Tomography Is Transforming Postradiation Therapy Monitoring in Oligometastatic Prostate Cancer
errInternational Journal of Radiation Oncology Biology Physics
IF6.5
err2026-07-15
err0
PREAI
errSalvatore Cozzi; Daniele Brenna; Nicolas Vial; Camille Roukoz; Daniela E. Oprea-Lager; Thomas Zilli
errShare
errSave
When Patients Refuse Radical Cystectomy: Integrating Trimodality Therapy in the Perioperative ICI/ADC Era
errEuropean Urology Oncology
IF9.3
err2026-04-29
err0
PREAI
errMartino Pedrani; Alberto De Giorgi; Andrea Gallina; Ursula Vogl; Thomas Zilli
errShare
errSave
A comparative assessment of deep learning and knowledge-based dose prediction models for advanced radiotherapy planning of prostate cancer with focal boosting
errPhysics and Imaging in Radiation Oncology
IF3.3
err2026-04-23
err0
errOAAI
errMaria A. Piliero; Antonio Angrisani; Davide G. Bosetti; Margherita Casiraghi; Francesco Castronovo; Nicolas Vial; Salvatore Cozzi; Matteo Coppotelli; Klaudia Krzekotowska; Lisa Milan; Francesco Pupillo; Stefano Presilla; Thomas Zilli
errShare
errSave
Efficacy and tolerability of hypofractionated and dose-boosted radiotherapy for localised prostate cancer: a systematic review and meta-analysis
errRadiotherapy and Oncology
IF5.3
err2026-02-17
err0
errOAAI
errMarcin Miszczyk; Nishan Sohoni; Shayan Smani; Matthias Moll; Ahmed R. Alfarhan; Navid Roessler; Keiichiro Miyajima; Shota Inoue; Giulia Marvaso; Federico Mastroleo; Constantinos Zamboglou; Timo F.W. Soeterik; Thomas Zilli; Mario Terlizzi; Pierre Blanchard; Paweł Rajwa; Tamás Fazekas; Guillaume Ploussard; Yi An; Michael S. Leapman
errShare
errSave
Dental metal artifacts in magnetic resonance-based synthetic computed tomography for brain radiotherapy: Impact on dose, patient setup, and geometric distortion
errPhysics and Imaging in Radiation Oncology
IF3.3
err2026-02-13
err0
errOAAI
errLisa Milan; Francesco Pupillo; Margherita Corsi; Matteo Coppotelli; Alessio Minoggio; Paula Sargenti; Stefano Moretto; Margherita Casiraghi; Maria Antonietta Piliero; Klaudia Krzekotowska; Davide Giovanni Bosetti; Gianfranco Pesce; Francesco Mosè Castronovo; Stefano Presilla; Thomas Zilli
errShare
errSave
Optimizing prostate cancer stereotactic body radiotherapy: margins, dose, or target volume-de-intensification?
errRadiotherapy and Oncology
IF5.3
err2026-02-11
err0
PREAI
errJennifer Le Guevelou; Paul Sargos; Thomas Zilli
errShare
errSave
Prognosis and Treatment Response in Aggressive-variant Prostate Cancer and Treatment-related Neuroendocrine Prostate Cancer: A Systematic Review and Meta-analysis
errEuropean Urology Oncology
IF9.3
err2026-02-10
err0
PREAI
errMartino Pedrani; Giuseppe Salfi; Giovanna Pecoraro; Marialuisa Puglisi; Fabio Turco; Luigi Tortola; Vasile Urechie; Gianmarco Leone; Hui-Ming Lin; Ursula Vogl; Jessica Barizzi; Giorgio Treglia; Marco Cuzzocrea; Gaetano Paone; Ping Lai; Jean Philippe Theurillat; Thomas Zilli; Silke Gillessen; Sara Merler; Ricardo Pereira Mestre
errShare
errSave
Re: Amar U. Kishan, Luca F. Valle, Holly Wilhalme, et al. 177Lu-Prostate-specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-label, Randomized, Controlled, Phase II Study. J Clin Oncol 2025;43:3812–21
errEuropean Urology Open Science
IF4.5
err2026-01-22
err0
errOAAI
errVérane Achard; Thomas Zilli; Bertrand Tombal
errShare
errSave
Health-related Quality of Life Outcomes of Salvage Metastasis-directed Treatment Versus Elective Nodal Treatment for Oligorecurrent Nodal Prostate Cancer: A Secondary Analysis of the Phase 2, Open-label PEACE V–STORM Randomized Trial
errEuropean Urology Oncology
IF9.3
err2026-01-20
err0
errOAAI
errThomas Zilli; Shankar Siva; Sigmund Brabrand; Piet Dirix; Nick Liefhooghe; François-Xavier Otte; Alfonso Gomez-Iturriaga; Wouter Everaerts; Mohamed Shelan; Antonio Conde-Moreno; Fernando López Campos; Alexandros Papachristofilou; Matthias Guckenberger; Marta Scorsetti; Almudena Zapatero; Ana-Elena Villafranca Iturre; Clara Eito; Felipe Couñago; Paolo Muto; Wim Duthoy
errShare
errSave
Interdisciplinary Swiss consensus recommendations for follow-up after radical cystectomy and trimodal treatment for muscle-invasive bladder cancer
errBladder Cancer
IF1.2
err2026-01-01
err0
PREAI
errKaufmann, Ernest; Aeppli, Stefanie; Affentranger, Andres; Arnold, Nicolas; Arnold, Winfried; Aschwanden, Fabian; Balermpas, Panagiotis; Beyer, Jorg; Bieri, Uwe; Boormanns, Joost; Cathomas, Richard; Bari, Berardino De; Dressler, Marco; Engeler, Daniel S.; Erdmann, Andreas; Gallina, Andrea; Gomez, Silvia; Guckenberger, Matthias; Herrmann, Thomas; Hermanns, Thomas; Lucca, Ilaria; John, Hubert; Kessler, Thomas Matthias; Klein, Jan; Laouiti, Mohamed; Lauffer, David; Lerner, Seth Paul; Mattei, Agostino; Muntener, Michael; Nguyen, Daniel; Niederberger, Philipp; Papachristofilou, Alexandros; Prause, Lukas; Putora, Paul Martin; Reinhardt, Karsten; Salati, Emanuela; Sebe, Philippe; Shelan, Mohamed; Sigg, Silvan; Strebel, Rato Thomas; Templeton, Arnoud Jan; Vogl, Ursula; Wettstein, Marian Severin; Wyler, Stephen; Zihler, Deborah; Zilli, Thomas; Zwahlen, Daniel; Roth, Beat; Fankhauser, Christian Daniel
errShare
errSave
Reducing adverse effects in hypofractionated radiotherapy for prostate cancer: Clinical evidence and emerging mitigation strategies
errProstate Cancer and Prostatic Diseases
IF5.8
err2025-12-23
err0
PREAI
errJennifer Le Guevelou; Thomas Zilli; Federica Ferrario; Vedang Murthy; Alison Tree; Andrew Loblaw; Uulke A. Van der Heide; Amar Kishan; Cédric Draulans; Jarad Martin; Piet Ost; Paul Sargos
errShare
errSave
Re: Markus Graefen, Fabian Falkenbach, Tobias Maurer, et al. Best Systemic Therapy With or Without Radical Prostatectomy in the Management of Men With Oligometastatic Prostate Cancer: The RAMPP Randomised Controlled Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.09.4144
errEuropean Urology
IF25.2
err2025-12-13
err0
PREAI
errSalvatore Cozzi; Thomas Zilli
errShare
errSave
Immunological factors underlying radiation-induced toxicity in prostate cancer patients: a systematic review
errDiscover Oncology
IF2.9
err2025-11-27
err0
errOAAI
errLucas Mose; Hady Aboelroos; Adam Zabini; Cristian Fernandez-Palomo; Thomas Zilli; Alan Dal Pra; Osama Mohamad; Daniel M. Aebersold; Verdiana Trappetti; Mohamed Shelan
errShare
errSave
Chasing the Culprit: targeting metastatic index lesions in oligometastatic hormone-sensitive prostate cancer
errProstate Cancer and Prostatic Diseases
IF5.8
err2025-11-25
err0
PREAI
errSalvatore Cozzi; Thomas Zilli
errShare
errSave
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024
errEuropean Journal of Cancer
IF7.1
err2025-11-21
err0
PREAI
errUrsula M. Vogl; Sara Merler; Antonio Angrisani; Fabio Turco; Ian D. Davis; Jason A. Efstathiou; Karim Fizazi; Nicholas D. James; Neal Shore; Eric J. Small; Matthew R. Smith; Christopher J. Sweeney; Bertrand Tombal; Thomas Zilli; Ken Herrmann; Aurelius Omlin; Silke Gillessen
errShare
errSave
Therapeutic outcomes of ²²⁵Ac/¹⁷⁷Lu-PSMA combination therapy in advanced metastatic Castration-Resistant prostate cancer: A systematic review and Meta-Analysis
errEuropean Journal of Nuclear Medicine and Molecular Imaging
IF7.6
err2025-11-18
err0
errOAAI
errZineddine Belabaci; Giulio Brignoli; Thomas Zilli; Miloš Grujić; Issa Mohamad; Akram Al-Ibraheem; Mohamed Shelan; Ali Afshar-Oromieh
errShare
errSave
Re: Carlo Andrea Bravi, Sophie Knipper, Axel Heidenreich, et al. Oncologic Outcomes of Template Versus Radioguided Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography Scan: Results from a Multi-institutional Collaboration. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2025.05.019
errEuropean Urology Focus
IF5.6
err2025-11-07
err0
PREAI
errGiulio Francolini; Piet Ost; Thomas Zilli
errShare
errSave
Radiotherapy plus Long-term Adjuvant Androgen Deprivation with a Luteinizing Hormone–releasing Hormone Antagonist Versus Agonist in Patients with Very High-risk Localized or Locally Advanced Prostate Cancer: The EORTC GUCG-1414 Phase 3 Randomized Trial
errEuropean Urology Oncology
IF9.3
err2025-11-07
err0
errOAAI
errThomas Zilli; Dirk Böhmer; Andreas Roeder; David Lauffer; Ana Elena Villafranca Iturre; Josep Jové Jové-Teixidó; Stéphane Supiot; Igor Latorzeff; Piet Dirix; François-Xavier Otte; Giulio Francolini; Thierry Roumeguère; Jean Marc Simon; Beatrice Fournier; Catherine Fortpied; Pedro C. Lara; Bertrand Tombal
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
S
Shahrokh F. Shariat
H-index: 146 · Papers: 2.9K
F
Fred Saad
H-index: 127 · Papers: 1.9K
M
Martin Gleave
H-index: 126 · Papers: 1.8K
K
Karim Fizazi
H-index: 123 · Papers: 1.5K
G
Giovanni B. Frisoni
H-index: 120 · Papers: 1.2K
View more